BioNTech (BNTX) Earnings Date, Estimates & Call Transcripts

$88.49

-0.50 (-0.56%)

(As of 11:07 AM ET)

Upcoming Earnings Date: Nov. 4Estimated
Actual EPS (Aug. 5): -$3.36 Missed By -$1.34
Consensus EPS (Aug. 5): -$2.02

BNTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BNTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Stansberry Research

The Strange Disappearance of MILLIONS of American Jobs

A former hedge fund manager who bought Apple at a split-adjusted 35 cents and Amazon at $2.40 (split adjusted) just went issued a major warning.

You can watch our interview, here, free of charge.

BioNTech Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2024	3	($1.02)	$1.26	($0.08)
Q2 2024	3	($1.76)	($1.05)	($1.35)
Q3 2024	3	($1.33)	$2.98	$0.83
Q4 2024	3	$0.62	$2.76	$2.03
FY 2024	12	($3.49)	$5.95	$1.43
Q1 2025	1	($2.36)	($2.36)	($2.36)
Q2 2025	1	($2.37)	($2.37)	($2.37)
Q3 2025	1	$0.82	$0.82	$0.82
Q4 2025	1	$0.79	$0.79	$0.79
FY 2025	4	($3.12)	($3.12)		($3.12)

BNTX Earnings Date and Information

BioNTech last released its earnings results on August 5th, 2024. The reported ($3.36) earnings per share for the quarter, missing the consensus estimate of ($2.02) by $1.34. The firm had revenue of $128.70 million for the quarter, compared to the consensus estimate of $134.98 million. Its revenue for the quarter was down 23.3% on a year-over-year basis. BioNTech has generated $0.50 earnings per share over the last year ($0.50 diluted earnings per share) and currently has a price-to-earnings ratio of 177.7. Earnings for BioNTech are expected to decrease in the coming year, from ($2.04) to ($2.09) per share. BioNTech has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off prior year's report dates.

BioNTech Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
11/4/2024 (Estimated)	-	-	-	-	-	-	-
8/5/2024	Q2 2024	($2.02)	($3.36)	($1.34)	($3.62)	$134.98 million	$128.70 million
5/6/2024	Q1 2024	($0.82)	($1.42)	($0.60)	($1.42)	$589.96 million	$203.69 million
3/20/2024	Q4 2023	$2.64	$2.05	($0.59)	$2.05	$2.04 billion	$1.59 billion
11/6/2023	Q3 2023	($0.59)	$0.67	+$1.26	$0.73	$850.50 million	$895.30 million
8/7/2023	Q2 2023	($0.83)	($0.79)	+$0.04	($0.86)	$628.13 million	$167.70 million
5/8/2023	Q1 2023	$0.18	$2.05	+$1.87	$2.20	$1.09 billion	$1.28 billion
Get the Latest News and Ratings for BNTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BioNTech and its competitors with MarketBeat's FREE daily newsletter.
3/27/2023	Q4 2022	$8.04	$9.26	+$1.22	$9.46	$3.87 billion	$4.28 billion
11/7/2022	Q3 2022	$3.66	$7.04	+$3.38	$7.04	$1.90 billion	$3.46 billion
8/8/2022	Q2 2022	$7.69	$7.31	($0.38)	$7.31	$4.11 billion	$3.20 billion
5/9/2022	Q1 2022	$9.14	$15.98	+$6.84	$15.98	$4.50 billion	$6.37 billion
3/30/2022	Q4 2021	$8.02	$13.93	+$5.91	$13.93	$3.83 billion	$5.53 billion
11/8/2021	Q3 2021	$10.54	$12.35	+$1.81	$14.56	$5.02 billion	$6.09 billion
8/8/2021	Q2 2021	$8.35	$10.77	+$2.42	$12.98	$3.27 billion	$5.31 billion
5/9/2021	Q1 2021	$3.09	$4.39	+$1.30	$5.29	$1.40 billion	$2.05 billion
3/29/2021	Q4 2020	($0.56)	$1.57	+$2.13	$1.87	$98.29 million	$412.00 million
11/15/2020	Q3 2020	($0.37)	($0.88)	($0.51)	($1.03)	$50.53 million	$67.50 million
8/11/2020	Q2 2020	($0.06)	($0.38)	($0.32)	($0.42)	$84.52 million	$41.80 million
5/12/2020	Q1 2020	($0.30)	($0.26)	+$0.04	($0.26)	$27.90 million	$30.51 million
3/31/2020	Q4 2019	($0.19)	($0.29)	($0.10)	($0.29)	$32.86 million	$31.00 million
11/14/2019	Q3 2019	($0.21)	($0.16)	+$0.05	($0.16)	$28.83 million	$31.87 million

BioNTech Earnings - Frequently Asked Questions

When is BioNTech's earnings date?: BioNTech has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off last year's report dates. Learn more on BNTX's earnings history.
What guidance has BioNTech issued on next quarter's earnings?: BioNTech updated its FY 2024 earnings guidance on Monday, August, 5th. The company issued revenue guidance of $2.7 billion-$3.3 billion, compared to the consensus revenue estimate of $3.0 billion.
Did BioNTech beat their earnings estimates last quarter?: In the previous quarter, BioNTech (NASDAQ:BNTX) missed the analysts' consensus estimate of ($2.02) by $1.34 with a reported earnings per share (EPS) of ($3.36). Learn more on analysts' earnings estimate vs. BNTX's actual earnings.
How can I listen to BioNTech's earnings conference call?: The conference call for BioNTech's latest earnings report can be listened to online. Listen to Conference Call
How can I read BioNTech's conference call transcript?: The conference call transcript for BioNTech's latest earnings report can be read online. Read Transcript
How much revenue does BioNTech generate each year?: BioNTech (NASDAQ:BNTX) has a recorded annual revenue of $2.69 billion.
How much profit does BioNTech generate each year?: BioNTech (NASDAQ:BNTX) has a recorded net income of $1.01 billion. BNTX has generated $0.50 earnings per share over the last four quarters.
What is BioNTech's price-to-earnings ratio?: BioNTech (NASDAQ:BNTX) has a trailing price-to-earnings ratio of 177.72.
What is BioNTech's EPS forecast for next year?: BioNTech's earnings are expected to decrease from ($2.04) per share to ($2.09) per share in the next year.